- Home
- BH vs QURE Comparison
BH vs QURE Comparison
Compare BH & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BH
- QURE
- Stock Information
- Founded
- BH 1934
- QURE 1998
- Country
- BH United States
- QURE Netherlands
- Employees
- BH N/A
- QURE N/A
- Industry
- BH Restaurants
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- BH Consumer Discretionary
- QURE Health Care
- Exchange
- BH Nasdaq
- QURE Nasdaq
- Market Cap
- BH 904.4M
- QURE 725.4M
- IPO Year
- BH N/A
- QURE 2007
- Fundamental
- Price
- BH $305.05
- QURE $15.70
- Analyst Decision
- BH
- QURE Strong Buy
- Analyst Count
- BH 0
- QURE 10
- Target Price
- BH N/A
- QURE $36.90
- AVG Volume (30 Days)
- BH 24.0K
- QURE 1.1M
- Earning Date
- BH 08-08-2025
- QURE 07-29-2025
- Dividend Yield
- BH N/A
- QURE N/A
- EPS Growth
- BH N/A
- QURE N/A
- EPS
- BH 146.55
- QURE N/A
- Revenue
- BH $377,176,000.00
- QURE $14,337,000.00
- Revenue This Year
- BH N/A
- QURE N/A
- Revenue Next Year
- BH N/A
- QURE $278.91
- P/E Ratio
- BH $23.32
- QURE N/A
- Revenue Growth
- BH 4.14
- QURE N/A
- 52 Week Low
- BH $159.69
- QURE $4.45
- 52 Week High
- BH $328.65
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- BH 55.27
- QURE 59.17
- Support Level
- BH $291.74
- QURE $14.70
- Resistance Level
- BH $318.36
- QURE $16.66
- Average True Range (ATR)
- BH 12.76
- QURE 0.80
- MACD
- BH 0.69
- QURE 0.17
- Stochastic Oscillator
- BH 70.40
- QURE 74.54
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.